UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 233

Sortiert nach

Highly reactive anti-myelin oligodendrocyte glycoprotein antibodies differentiate demyelinating diseases from viral encephalitis in children

Multiple sclerosis, 2011-03, Vol.17 (3), p.297-302

2011

Volltextzugriff (PDF)

Fatal PML associated with efalizumab therapy: insights into integrin αLβ2 in JC virus control

Neurology, 2012-02, Vol.78 (7), p.458

2012

Volltextzugriff (PDF)

Patient monitoring 4.0

Nervenarzt, 2019-12, Vol.90 (12), p.1205-1206

2019

Volltextzugriff (PDF)

Multiple sclerosis - a dynamic field with a need for excellent education

European journal of neurology, 2015-10, Vol.22 (S2), p.1-2

Kieseier, B.C.

2015

Volltextzugriff (PDF)

A 10-year follow-up of the European multicenter trial of interferon β-1b in secondary-progressive multiple sclerosis

Multiple sclerosis, 2016-04, Vol.22 (4), p.533-543

2016

Volltextzugriff (PDF)

Optical coherence tomography measures axonal loss in multiple sclerosis independently of optic neuritis

Journal of neurology, 2007-11, Vol.254 (11), p.1595-1596

2007

Volltextzugriff (PDF)

Regulation of matrix metalloproteinases and their inhibitors by interferon-β: a longitudinal study in multiple sclerosis patients

Multiple sclerosis, 2009-06, Vol.15 (6), p.721-727

2009

Volltextzugriff (PDF)

The Global Adherence Project (GAP): a multicenter observational study on adherence to disease-modifying therapies in patients with relapsing-remitting multiple sclerosis

European journal of neurology, 2011-01, Vol.18 (1), p.69-77

2011

Volltextzugriff (PDF)

Matrix metalloproteinases in inflammatory demyelination: targets for treatment

Neurology, 1999-07, Vol.53 (1), p.20

1999

Volltextzugriff (PDF)

Monomethylfumarate reduces in vitro migration of mononuclear cells

Neurological sciences, 2014-07, Vol.35 (7), p.1121-1125

2014

Volltextzugriff (PDF)

Expression of CD28-related costimulatory molecule and its ligand in inflammatory neuropathies

Neurology, 2007-01, Vol.68 (4), p.277

2007

Volltextzugriff (PDF)

Matrix metalloproteinase-9 and -7 are regulated in experimental autoimmune encephalomyelitis

Brain (London, England : 1878), 1998, Vol.121 (1), p.159-166

1998

Volltextzugriff (PDF)

Immunobiology of muscle: advances in understanding an immunological microenvironment

Trends in immunology, 2005-07, Vol.26 (7), p.373-380

2005

Volltextzugriff (PDF)

Leopold Ordenstein: on paralysis agitans and multiple sclerosis

Multiple sclerosis, 2007-11, Vol.13 (9), p.1195-1199

2007

Volltextzugriff (PDF)

Matrix metalloproteinases MMP-9 and MMP-7 are expressed in experimental autoimmune neuritis and the guillain-barré syndrome

Annals of neurology, 1998-04, Vol.43 (4), p.427-434

1998

Volltextzugriff (PDF)

Changes to anti-JCV antibody levels in a Swedish national MS cohort

Journal of neurology, neurosurgery and psychiatry, 2013-11, Vol.84 (11), p.1199-1205

2013

Volltextzugriff (PDF)

Interferon beta treatment does not induce organ-specific autoantibodies in multiple sclerosis

Neurology, 2009-09, Vol.73 (11), p.900

2009

Volltextzugriff (PDF)

Patientenmonitoring 4.0

Nervenarzt, 2019-12, Vol.90 (12), p.1205-1206

2019

Volltextzugriff (PDF)

Interferon-β enhances monocyte and dendritic cell expression of B7-H1 (PD-L1), a strong inhibitor of autologous T-cell activation: relevance for the immune modulatory effect in multiple sclerosis

Journal of neuroimmunology, 2004-10, Vol.155 (1), p.172-182

2004

Volltextzugriff (PDF)

Safety and Clinical Outcomes of Rituximab Treatment in Patients with Multiple Sclerosis and Neuromyelitis Optica: Experience from a National Online Registry (GRAID)

Journal of neuroimmune pharmacology, 2016-03, Vol.11 (1), p.1-8

2016

Volltextzugriff (PDF)

Teriflunomide for treatment of multiple sclerosis

Nervenarzt, 2013-06, Vol.84 (6), p.724

2013

Volltextzugriff (PDF)

A 10-year follow-up of the European multicenter trial of interferon beta -1b in secondary-progressive multiple sclerosis

Multiple sclerosis, 2016-04, Vol.22 (4), p.533-543

2016

Volltextzugriff (PDF)

Differential expression of matrix metalloproteinases in bacterial meningitis

Brain (London, England : 1878), 1999-08, Vol.122 (8), p.1579-1587

1999

Volltextzugriff (PDF)

Bacteria and their cell wall components uniformly co‐activate interleukin‐17‐producing thymocytes

Clinical and experimental immunology, 2014-12, Vol.178 (3), p.504-515

2014

Volltextzugriff (PDF)

T cell activation status determines the cytokine pattern induced by zymosan and bacterial DNA both in thymocytes and splenocytes

Clinical and experimental immunology, 2013-05, Vol.172 (2), p.245-253

2013

Volltextzugriff (PDF)

1 – 25 von 233

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(216)
Mit Volltextzugriff
(201)

Publikationsform

Sprache

Englisch
(158)
Deutsch
(79)
Japanisch
(19)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Highly reactive anti-myelin oligodendrocyte glycoprotein antibodies differentiate demyelinating diseases from viral encephalitis in children

Fatal PML associated with efalizumab therapy: insights into integrin αLβ2 in JC virus control

Patient monitoring 4.0

Multiple sclerosis - a dynamic field with a need for excellent education

A 10-year follow-up of the European multicenter trial of interferon β-1b in secondary-progressive multiple sclerosis

Optical coherence tomography measures axonal loss in multiple sclerosis independently of optic neuritis

Regulation of matrix metalloproteinases and their inhibitors by interferon-β: a longitudinal study in multiple sclerosis patients

The Global Adherence Project (GAP): a multicenter observational study on adherence to disease-modifying therapies in patients with relapsing-remitting multiple sclerosis

Matrix metalloproteinases in inflammatory demyelination: targets for treatment

Monomethylfumarate reduces in vitro migration of mononuclear cells

Expression of CD28-related costimulatory molecule and its ligand in inflammatory neuropathies

Matrix metalloproteinase-9 and -7 are regulated in experimental autoimmune encephalomyelitis

Immunobiology of muscle: advances in understanding an immunological microenvironment

Leopold Ordenstein: on paralysis agitans and multiple sclerosis

Matrix metalloproteinases MMP-9 and MMP-7 are expressed in experimental autoimmune neuritis and the guillain-barré syndrome

Changes to anti-JCV antibody levels in a Swedish national MS cohort

Interferon beta treatment does not induce organ-specific autoantibodies in multiple sclerosis

Patientenmonitoring 4.0

Interferon-β enhances monocyte and dendritic cell expression of B7-H1 (PD-L1), a strong inhibitor of autologous T-cell activation: relevance for the immune modulatory effect in multiple sclerosis

Safety and Clinical Outcomes of Rituximab Treatment in Patients with Multiple Sclerosis and Neuromyelitis Optica: Experience from a National Online Registry (GRAID)

Teriflunomide for treatment of multiple sclerosis

A 10-year follow-up of the European multicenter trial of interferon beta -1b in secondary-progressive multiple sclerosis

Differential expression of matrix metalloproteinases in bacterial meningitis

Bacteria and their cell wall components uniformly co‐activate interleukin‐17‐producing thymocytes

T cell activation status determines the cytokine pattern induced by zymosan and bacterial DNA both in thymocytes and splenocytes

Suchergebnisse filtern